Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers

Autor:	Thomas Antoine-Moussiaux, Laurent Blairon, Ingrid Beukinga, Marie Tré-Hardy, Alexandra Horeanga, Alain Wilmet, Andrea Della Vecchia, Roberto Cupaiolo, Emmanuelle Papleux, Marc Vekemans
Jazyk:	angličtina
Rok vydání:	2021
Předmět:	Microbiology (medical) 2019-20 coronavirus outbreak COVID-19 Vaccines Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Article Health personnel Humans Medicine BNT162 Vaccine Messenger RNA Reactogenicity business.industry SARS-CoV-2 Vaccination COVID-19 Généralités Virology Immunogenicity immunogenicity reactogenicity safety mRNA-1273 vaccine mRNA-1273 vaccine Infectious Diseases Antibody response Safety business Antibody formation Immunogenicity Reactogenicity Safety mRNA-1273 vaccine
Zdroj:	The Journal of infection Tré-Hardy, M, Cupaiolo, R, Papleux, E, Wilmet, A, Horeanga, A, Antoine-Moussiaux, T, Della Vecchia, A, Beukinga, I, Vekemans, M & Blairon, L 2021, ' Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers ', Journal of Infection, vol. 83, no. 2, pp. 237-279 . https://doi.org/10.1016/j.jinf.2021.03.025 The Journal of Infection
DOI:	10.1016/j.jinf.2021.03.025
Popis:	SCOPUS: le.j info:eu-repo/semantics/published
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::232e7f9dc65979a7adf5a7bb0c9b4252 http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/325022 Zobrazit plný text záznamu